CraniUS Therapeutics targets a specific bottleneck in CNS drug delivery with its implantable convection-enhanced delivery system, enabling repeated, localized dosing beyond the blood–brain barrier. This positions it as enabling infrastructure for neuro-oncology therapies rather than a standalone therapeutic company.